← Sites
717 (USA)
USA
PI: Dr. Reyes
activated
KRI 0.0
Patients
7
Active (enrolled/consented)
0
Withdrawn
0
Serious AEs
0
Open QA findings
0
Aged data queries
0
Studies & contracts total budget 111500.00 USD
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
study completed
contract executed
111500 USD
Patients first 7
| Ref | Status | Consented | Study |
|---|---|---|---|
| 717-1004 | completed | 2014-01-14 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 717-1109 | completed | 2014-01-27 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 717-1174 | completed | 2013-01-22 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 717-1201 | completed | 2013-12-19 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 717-1344 | completed | 2014-01-11 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 717-1357 | completed | 2013-05-01 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
| 717-1446 | completed | 2013-09-01 | Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. |
Luna participants (0)
No participants at this site use Luna yet.
Safety 58 AEs · 0 serious
No serious adverse events at this site.
QA findings 0 open
No findings recorded.
Monitoring visits (0)
No visits recorded.
Payments (0)
No payments on file.